ALQGC Share Price Performance
€0.072
-0.02 (-21.86%)
Price €0.072
Share Price€0.072
ALQGC Community Narratives
There are no narratives available yet.
Recent ALQGC News & Updates
No updates
Quantum Genomics Société Anonyme Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.13
- Gross Margin
- -11,453,070.00%
- Net Profit Margin
- -88,926,030.00%
- Debt/Equity Ratio
- -107.4%
Quantum Genomics Société Anonyme Competitors
About ALQGC
- Founded
- 2005
- Employees
- 1
- CEO
- WebsiteView website
Quantum Genomics Société Anonyme, a healthtech company, develops of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.
French Market Performance
- 7 Days: -2.6%
- 3 Months: -1.7%
- 1 Year: 5.2%
- Year to Date: 1.6%
Over the last 7 days, the market has dropped 2.6%, driven by a pullback of 7.6% in the Consumer Discretionary sector. As for the longer term, the market has actually risen by 5.2% in the last year. Earnings are forecast to grow by 12% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading